Evaluation of relacorilant as a glucocorticoid receptor modulator for maintenance therapy following standard first-line treatment in ovarian cancer organoid models

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Sarah Joy Baron, Sonali Kaushik, Hazel Hunt, Rebecca Herberston, Kate Lankester, Melanie Sarah Flint

DOI: 10.1016/j.ijgc.2025.103997

Cited by: 1

Fields of Study & Subjects

Estrogen and related hormone effects Ovarian cancer diagnosis and treatment Cancer Stress Anesthesia and Immune Response